Protagenic Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/10/2023 | 236.31 K | $94.52 K | -6.53% | 5.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 103.60 K | $43.00 K | -0.27% | 2.40% |
| FNY INVESTMENT ADVISERS, LLC | 01/10/2023 | 75.00 K | $31.00 K | 0.00% | 1.74% |
| STATE STREET CORP | 05/15/2023 | 55.25 K | $23.09 K | 0.00% | 1.28% |
| CITADEL ADVISORS LLC | 02/14/2023 | 23.48 K | $9.82 K | 45.58% | 0.54% |
| NORTHERN TRUST CORP | 02/13/2023 | 22.49 K | $8.99 K | 0.00% | 0.52% |
| WARBERG ASSET MANAGEMENT LLC | 02/13/2023 | 20.00 K | $8.00 K | 100.00% | 0.46% |
| UBS GROUP AG | 02/08/2023 | 17.15 K | $6.86 K | 164.83% | 0.40% |
| CONCORDE ASSET MANAGEMENT, LLC | 02/02/2023 | 16.72 K | $6.69 K | 0.00% | 0.39% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 13.98 K | $5.84 K | 100.00% | 0.32% |
| ADVISOR GROUP HOLDINGS, INC. | 02/10/2023 | 11.06 K | $4.00 K | 0.00% | 0.26% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 10.11 K | $4.00 K | -4.44% | 0.23% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 6.21 K | $2.00 K | -4.92% | 0.14% |
| WELLS FARGO & COMPANY/MN | 02/13/2023 | 90 | $36 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/10/2023 | 4 | $2 | 100.00% | 0.00% |
| CWM, LLC | 02/01/2023 | 3 | $0 | 0.00% | 0.00% |
| MORGAN STANLEY | 02/14/2023 | 1 | $0 | -50.00% | 0.00% |
| HARBOR INVESTMENT ADVISORY, LLC | 01/24/2023 | 1 | $0 | 0.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 01/30/2023 | 0 | $0 | 0.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protagenic Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Protagenic Therapeutics, Inc.. The most heavily invested institutionals were:
CT Financial Advisors LLC: 1
14.16% of Protagenic Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1 shares in the last 24 months. This purchase volume represents approximately $3 in transactions.